One important change, compared to the previous WHO CNS4 classification, is that glioblastoma is a more restricted diagnosis, encompassing diffuse and astrocytic IDH-wildtype tumors, typically harboring TERT promoter mutation and/or EGFR gene amplification and/or +7/−10 chromosome copy number changes. The gene discussed is IDH2; the disease is glioblastoma.